GlaxoSmithKline Pharmaceuticals P/B Ratio
GlaxoSmithKline Pharmaceuticals P/B ratio. GlaxoSmithKline Pharmaceuticals (GLAXO) P/B ratio is 24.26 (High), book value per share ₹134.14 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Browse GLAXO cash flow statement for revenue, profit, balance sheet and cash flow data.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
GLAXO P/B Ratio — Valuation Insights & Book Value Analysis
GlaxoSmithKline Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 24.26 (High). Read GLAXO dividend yield for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 24.26, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 35.0% above historical average
- Trading at premium to sector average PB of -0.3
GlaxoSmithKline Pharmaceuticals P/B Ratio Historical Trend
GLAXO annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see GlaxoSmithKline Pharmaceutical stock price NSE.
GLAXO Historical P/B Ratio — Book Value Per Share & Year-End Price
GlaxoSmithKline Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 20.23 | ₹134.14 | ₹2713.40 | ₹2,267 | High |
| 2025 | 21.43 | ₹115.44 | ₹2473.60 | ₹1,951 | High |
| 2024 | 21.4 | ₹105.21 | ₹2251.85 | ₹1,778 | High |
| 2023 | 18.43 | ₹103.02 | ₹1898.15 | ₹1,741 | High |
| 2022 | 8.37 | ₹157.57 | ₹1318.75 | ₹2,663 | High |
GLAXO vs Healthcare Peers — P/B Ratio Comparison
GlaxoSmithKline Pharmaceuticals P/B 24.26 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |